
Light4Lungs
Transforming lung Infection treatment
Light4Lungs tackled antimicrobial resistance in treating chronic lung infections, such as those caused by cystic fibrosis and hospital-acquired infections, by developing a novel inhalable photodynamic therapy using breathable light sources. This drug-free approach bypassed multidrug resistance and avoided invasive methods, focusing on luminescent particles and aerosol technology for targeted lung delivery.
The project aimed to revolutionize treatment for respiratory infections and other lung diseases,
with potential applications in healthcare, nanomedicine, and materials science.
Wedo’s role in Light4lungs



Social media






Comunicacion impressa

Conference





Online streaming



L4L Open Event | Closing Session
L4L Open Event | Dr Enric Claverol
L4L Open Event | Dr Roberto Pini
L4L Open Event | Dr Giovanni Romano
L4L PARTNERS








Funding information

Funding organization
EC / H2020 – FET Ope

Timeframe
December 2019 – November 2023

Funding amount
3,493,625.00 €

Coordinator
INSTITUT QUIMIC DE SARRIA
(IQS-URL)
Back to projects
Interested in learning more about L4L?